DeepChek® Assay NS3 Genotyping and Drug Resistance

A research-use HCV NS3 genotyping and drug-resistance assay for PCR amplification from plasma or serum RNA, compatible with Sanger and NGS workflows.

HCV Genotyping & Drug Resistance

NS3 Genotyping & Drug Resistance

RUO

The NS3 assay is a single-tube PCR system for amplifying relevant portions of the HCV NS3 gene from plasma or serum RNA. It is positioned for genotyping and drug-resistance workflows with Sanger and NGS compatibility.

Sequencing workflow HCV DeepChek portfolio

DeepChek Assay NS3 Genotyping and Drug Resistance

Key Details

Targets the HCV NS3 gene for genotyping and drug-resistance workflows.
Uses RNA extracted from plasma or serum.
Compatible with Sanger and NGS workflow paths.
Available as part of the special NS5A + NS3 + NS5B drug-resistance bundle.

Workflow Snapshot

Target regionNS3

WorkflowSingle-tube PCR amplification

Sample inputRNA extracted from plasma or serum

SequencingSanger and NGS compatible

Bundle optionNS5A + NS3 + NS5B

PositioningGenotyping and drug resistance

Ordering Information

Product	Reference
DeepChek Assay NS3 Genotyping and Drug Resistance (RUO)	108A24
Special Bundle: DeepChek Assay NS5A + NS3 + NS5B Genotyping & Drug Resistance (RUO)	105A24 + 108A24 + 107D24
DeepChek - HCV Software / Module (CE-IVD)	S12-023 (CL) / S12-023 (CM)

Implementation Note

Use this page for NS3-specific HCV drug-resistance conversations or as part of the broader NS3/NS5A/NS5B bundle.

Back To HCV Portfolio

Related HCV Assays

View All HCV Assays